Precision Oncology in Practice: Transforming Non–Small Cell Lung Cancer Care Through Advanced Biomarker Testin...
0.75 Credit / Oncology
View More
Finding Balance Between Advancement and Application: A Guide for Community Oncology Pharmacists on CAR T-Cell ...
0.75 Credit / Oncology, Hematologic Cancer
View More
Ensuring the Safe, Effective, and Equitable Care of Patients With Advanced Endometrial Cancer: Strategies for ...
0.75 Credit / Oncology
View More
Navigating the Use of Bispecific Antibodies in Non-Hodgkin Lymphoma: Solutions to Enhance Community-Based Care
0.75 Credit / Oncology
View More
Navigating Myelofibrosis: Tailored Treatments and Holistic Patient Support
0.75 Credit / Oncology
View More
The Role of Daily Photoprotection and Antioxidants in Sun Protection: A Guide for Pharmacists and Pharmacy Tec...
1.0 Credit / Dermatology, OTC
View More
Understanding the Role of Ceramides in Acne Management: Opportunities to Improve Clinical Outcomes (Pharmacy T...
1.0 Credit / Dermatology, OTC
View More
Skin-Related Changes in Persons With Diabetes: Using Ceramides to Address Skin Barrier Dysfunction (Pharmacy T...
1.0 Credit / Dermatology, OTC
View More
JAK1 Inhibitor NS-229 Granted FDA Orphan Drug Designation to Treat Allergic Autoimmune Condition
April 25th 2025NS-229 is a Janus kinase 1 (JAK1) inhibitor being investigated in eosinophilic granulomatosis with polyangiitis, a rare autoimmune condition that can cause severe allergic and asthmatic symptoms through inflammation of nerve cells.